Core Viewpoint - The application for Roxithromycin suspension by Xinhua Pharmaceutical (Gaomi) Co., Ltd. has been accepted by the National Medical Products Administration on March 26, 2026, with acceptance number CYHB2600592 [1][3]. Company Information - Company Name: Xinhua Pharmaceutical (Gaomi) Co., Ltd. [2][5] - Established Date: December 29, 2000 [5] - Legal Representative: Xu Wenhui [5] - Industry: Biopharmaceutical Manufacturing [5] - Company Type: Limited Liability Company (non-natural person investment or holding) [5] - Company Size: Small [5] - Number of Employees: 239 [5] - Registered Capital: 19 million RMB [5] - Paid-in Capital: 19 million RMB [5] - Registered Address: No. 6, West High-tech Industrial Development Zone, Gaomi City, Weifang, Shandong Province [5]. Shareholder Information - Shareholder: Shandong Xinhua Pharmaceutical Co., Ltd. [5] - Shareholding Ratio: 100% [5] - Contributed Capital: 19 million RMB [5] - Contribution Date: May 10, 2012 [5] - First Shareholding Date: April 11, 2012 [5].